Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood

New England Journal of Medicine

Volumn 334, Issue 22, 1996, Pages 1428-1434

  Ravindranath, Yaddanapudi ^a,k   Yeager, Andrew M ^b   Chang, Myron N ^c   Steuber, C Philip ^d   Krischer, Jeifrey ^e   Graham Pole, John ^f   Carrole, Andrew ^g   Inoue, Susumu ^h   Camitta, Bruce ⁱ   Weinstein, Howard J ^j  

^a WAYNE STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c University of Florida ^*  (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h HURLEY MEDICAL CENTER   (United States)

ⁱ CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k Pediatric Oncology Group   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DAUNORUBICIN; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN SYNDROME; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REMISSION; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID; SURVIVAL ANALYSIS; THIOGUANINE; TRANSPLANTATION, AUTOLOGOUS;

EID: 9344226161     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605303342203     Document Type: Article

References (31)

1. Weinstein HJ, Mayer RJ, Rosenthal DS, Coral FS, Camitta BM, Gelber RD. Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 1983;62:315-9.
2. Grier HE, Gelber RD, Camitta BM, et al. Prognostic factors in childhood acute myelogenous leukemia. J Clin Oncol 1987;5:1026-32.
3. Creutzig U, Ritter J, Riehm H, et al. Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78. Blood 1985;65:298-304.
4. Steuber CP, Civin C, Krischer J, et al. A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study. J Clin Oncol 1991;9:247-58.
5. Nesbit ME Jr, Buckley JD, Feig SA, et al. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. J Clin Oncol 1994;12:127-35.
6. Woods WG, Ruymann FB, Lampkin BC, et al. The role of timing high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia. Cancer 1990;66:1106-13.
7. Ravindranath Y, Steuber CP, Krischer J, et al. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study. J Clin Oncol 1991;9:572-80.
8. Sanders JE, Thomas ED, Buckner CD, et al. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update. Blood 1985;66:460-2.
9. Bostrom B, Brunning RD, McGlave P, et al. Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors. Blood 1985;65:1191-6.
10. Graham-Pole J. Treating acute lymphoblastic leukaemia after relapse: bone marrow transplantation or not? Lancet 1989;2:1517-8.
11. Yeager AM, Kaizer H, Santos GW, et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 1986;315:141-7.
12. Appelbaum FR, Clift RA, Buckner CD, et al. Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 1983; 61:949-53.
13. Gorin NC, Aegerter P, Auvert B, et al. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 1990;75:1606-14.
14. McMillan AK, Goldstone AH, Linch DC, et al. High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia. Blood 1990;76:480-8.
15. Löwenberg B, Verdonck LJ, Dekker AW, et al. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 1990;8:287-94.
16. Hakami N, Look AT, Steuber PC, et al. Combined etoposide and 5-azacitidine in children and adolescents with refractory or relapsed acute nonlymphocytic leukemia: a Pediatric Oncology Group study. J Clin Oncol 1987; 5:1022-5.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:475-81.
18. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
19. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures. J R Stat Soc [A] 1972;135:185-206.
20. Ravindranath Y, Abella E, Krischer JP, et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood 1992;80:2210-4.
21. Cassileth PA, Andersen J, Lazarus HM, et al. Autologous bone marrow transplant in acute myeloid leukemia in first remission. J Clin Oncol 1993; 11:314-9.
22. Burnett AK, Tansey P, Watkins R, et al. Transplantation of unpurged autologous bone-marrow in acute myeloid leukaemia in first remission. Lancet 1984;2:1068-70.
23. Appelbaum FR, Fisher LD, Thomas ED. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up. Blood 1988;72:179-84.
24. Reiffers J, Gaspard MH, Maraninchi D, et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial. Br J Haematol 1989;72:57-63.
25. Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. J Clin Oncol 1992;10:41-6.
26. Zittoun RA, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995;332:217-23.
27. Stevens RF, Hann IM, Burnett AK, Goldstone AH, Wheatley K, Gray RG. Improved outcome in paediatric acute myeloid leukemia: results of the MRCAML 10 trial. Med Pediatr Oncol 1994;23:172. abstract.
28. Amadori S, Testi AM, Arico M, et al. Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 1993;11:1046-54.
29. Woods WG, Kobrinsky N, Buckley J, et al. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol 1993;11:1448-57.
30. Creutzig U, Harbott J, Sperling C, et al. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood 1995;86:3097-108.
31. Woods WG, Kobrinsky N, Buckley J, et al. Timing intensive induction therapy improves post-remission outcome in acute myeloid leukemia (AML) irrespective of the use of bone marrow transplantation (BMT). Blood 1994; 84:Suppl 1:232a. abstract.